What is the Future of ATP Binding Site Inhibitors in Cancer Treatment?
The future of ATP binding site inhibitors in cancer treatment looks promising. Advances in precision medicine and drug design are enabling the development of more selective and potent inhibitors. Additionally, combination therapies that target multiple pathways simultaneously are being explored to overcome resistance and improve efficacy. Ongoing research is also focused on identifying new ATP binding site targets and understanding the molecular mechanisms underlying cancer progression.
